

Mohamad Mohty
MD, PhD, Saint-Antoine Hospital, Paris, France. Provides insights into current treatment approaches for acute and chronic GvHD, discussing the advent of new therapies.
Top 3 podcasts with Mohamad Mohty
Ranked by the Snipd community

Apr 17, 2025 • 23min
Highlights from EBMT 2025: preventing and managing GvHD, harnessing AI in transplant, & more
Join Mohamad Mohty, MD, PhD, from Saint-Antoine Hospital in Paris, as he dives into the latest advancements in preventing and managing graft-versus-host disease (GvHD). Learn about innovative therapies like Belumazidil and the complexities of CMV and HHV-6 infections after stem cell transplants. The discussion also highlights the potential of artificial intelligence in hematology, advocating for its role as a supportive tool for clinicians while ensuring compassionate patient care. It's a deep dive into the future of hematologic treatment!

Jul 8, 2024 • 16min
Updates on the use of BCMA-targeting bispecific antibodies in R/R multiple myeloma: insights from EHA & ASCO 2024
Guest Mohamad Mohty discusses updates on BCMA-targeting bispecific antibodies for multiple myeloma from EHA & ASCO 2024. Topics include MagnetisMM-3 trial data on elranatamab, real-world findings, step-up dosing of teclistamab, MAIC comparison of linvoseltamab with teclistamab, and sequencing of bispecific antibodies with CAR T-cells.

Apr 26, 2024 • 23min
Highlights from EBMT 2024: treating & managing GvHD & understanding the role of the gut microbiome
Experts Mohamad Mohty, Ernst Holler, and Florent Malard share insights on treating GvHD post stem cell transplant, discussing new therapies and the impact of the gut microbiome. Topics include novel agents like ruxolitinib, the role of antibiotics on gut health, benefits of FMT in refractory disorders, and the link between bacterial antigens and transplant outcomes.